Passage Bio Correlations

PASG Stock  USD 12.58  0.12  0.94%   
The current 90-days correlation between Passage Bio and Lisata Therapeutics is -0.03 (i.e., Good diversification). The correlation of Passage Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Passage Bio Correlation With Market

Very poor diversification

The correlation between Passage Bio and DJI is 0.8 (i.e., Very poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Passage Bio and DJI in the same portfolio, assuming nothing else is changed.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Passage Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more detail on how to invest in Passage Stock please use our How to Invest in Passage Bio guide.

Moving together with Passage Stock

  0.82SLS Sellas Life Sciences Downward RallyPairCorr
  0.76GNFT Genfit SAPairCorr
  0.71ANNX AnnexonPairCorr
  0.7APGE Apogee TherapeuticsPairCorr
  0.66CELC Celcuity LLCPairCorr
  0.75BCH Banco De Chile Normal TradingPairCorr
  0.7AEM Agnico Eagle MinesPairCorr
  0.62USAS Americas Silver Corp TrendingPairCorr

Moving against Passage Stock

  0.75GALT Galectin TherapeuticsPairCorr
  0.73RARE UltragenyxPairCorr
  0.69AAPG Ascentage Pharma Symbol ChangePairCorr
  0.68LEGN Legend Biotech CorpPairCorr
  0.61FNMFO Federal National MortgagePairCorr
  0.52ZLAB Zai LabPairCorr
  0.51CCCC C4 TherapeuticsPairCorr
  0.48AURA Aura BiosciencesPairCorr
  0.45KRRO Frequency TherapeuticsPairCorr
  0.41SGMO Sangamo TherapeuticsPairCorr
  0.37CNTA Centessa PharmaceuticalsPairCorr
  0.71HPQ HP IncPairCorr
  0.59T ATT Inc Earnings Call This WeekPairCorr
  0.58PG Procter GamblePairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

CASIALLR
CASICLGN
CLGNENLV
XCURCING
CASIENLV
ENLVALLR
  

High negative correlations

CINGGDTC
XCURCLGN
CLGNCING
CASIXCUR
CINGMTVA
XCURGDTC

Risk-Adjusted Indicators

There is a big difference between Passage Stock performing well and Passage Bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Passage Bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
NCNA  3.46 (0.64) 0.00 (0.40) 0.00 
 6.97 
 16.72 
MTVA  7.17 (1.38) 0.00  1.30  0.00 
 11.60 
 79.95 
LSTA  4.35  0.96  0.31  0.32  2.85 
 5.58 
 85.83 
ALLR  3.66 (0.38) 0.00 (0.14) 0.00 
 7.07 
 19.82 
GDTC  3.78 (1.33) 0.00 (2.35) 0.00 
 6.03 
 31.46 
ENLV  3.59  0.04  0.01  0.10  3.98 
 8.57 
 24.21 
CING  3.30  0.35  0.08  0.28  4.51 
 7.46 
 20.19 
CLGN  3.67 (0.28) 0.00  11.29  0.00 
 8.51 
 20.81 
XCUR  5.56  0.92  0.10 (0.61) 7.40 
 21.22 
 63.80 
CASI  3.72 (0.93) 0.00 (0.45) 0.00 
 5.88 
 32.11 

Passage Bio Corporate Management

Sue BrowneSenior DevelopmentProfile
Simona KingCFO SecProfile
JD EsqGeneral SecretaryProfile
Gregory FuestVice MarketingProfile
MSc MBAChief OfficerProfile
Kathleen BorthwickPrincipal FinanceProfile